marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q3
added 11-12-2024
Sangamo Therapeutics Cash Flow 2011-2024 | SGMO
Annual Cash Flow Sangamo Therapeutics
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
-225 M | -224 M | -233 M | 170 M | -144 M | 36.6 M | 11.2 M | -65.9 M | - | - | -19.5 M | -8.08 M | -25.9 M |
Depreciation & Amortization |
15.1 M | 12.1 M | 9.44 M | 5.68 M | 3.93 M | 2.36 M | 1.5 M | 997 K | 988 K | 549 K | 569 K | 660 K | 646 K |
Accounts Payables |
15.3 M | 22.4 M | 9.76 M | 12.6 M | 6.67 M | 3.36 M | 16 K | 2.58 M | 3.9 M | 5.52 M | 3.02 M | 3.05 M | - |
Accounts Receivables |
923 K | 3.68 M | 6.01 M | 5.22 M | 36.9 M | 4.67 M | 3.34 M | 4.97 M | 2.52 M | 10.4 M | 3.16 M | 4.13 M | 919 K |
Total Inventories |
- | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Cash Flow Sangamo Therapeutics
| 2024-Q3 | 2024-Q2 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
- | - | - | - | -66.3 M | - | -167 M | - | -59 M | - | -181 M | - | -68.6 M | - | 174 M | 141 M | -18.9 M | - | -124 M | -84.7 M | -45.1 M | - | 76.7 M | 104 M | -18.1 M | - | 28 M | 43.7 M | - | - | - | - | - | - | - | - | - | - | - | - | 11.4 M | - | - | - | -8.02 M | - | -8.3 M | -3.15 M | 2.87 M | - | -25.9 M | -19.4 M | -12 M |
Depreciation & Amortization |
- | - | - | - | 3.49 M | - | 8.76 M | - | 2.83 M | - | 6.68 M | - | 1.88 M | - | 4 M | 2.64 M | 1.31 M | - | 2.74 M | 1.58 M | 715 K | - | 1.67 M | 1.21 M | 588 K | - | 1.03 M | 618 K | 301 K | - | 745 K | 493 K | 245 K | - | 745 K | 428 K | 147 K | - | 400 K | 250 K | 123 K | - | 445 K | 305 K | 147 K | - | 500 K | 334 K | 168 K | - | 479 K | 319 K | 162 K |
Accounts Payables |
19.8 M | 17.6 M | 15.5 M | 14.8 M | 19.9 M | 22.4 M | 17.4 M | - | 11.1 M | 9.76 M | 7.98 M | 10.1 M | 11.6 M | 12.6 M | 12.6 M | 12.6 M | 12.6 M | 6.67 M | - | - | - | 3.36 M | - | - | - | 16 K | - | - | - | 2.58 M | - | - | - | 3.9 M | - | - | - | 5.52 M | - | - | - | 3.02 M | - | - | - | 3.05 M | - | - | - | 4.11 M | - | - | - |
Accounts Receivables |
10.5 M | 581 K | 1.15 M | 2.72 M | 7.03 M | 3.68 M | 4.52 M | - | 6.94 M | 6.01 M | 7.97 M | 6.88 M | 6.75 M | 5.22 M | 5.22 M | 5.22 M | 5.22 M | 36.9 M | 36.9 M | 36.9 M | 36.9 M | 4.67 M | 4.67 M | 4.67 M | 4.67 M | 3.34 M | 3.34 M | 3.34 M | 3.34 M | 4.97 M | 4.97 M | 4.97 M | 4.97 M | 2.52 M | 2.52 M | 2.52 M | 2.52 M | 10.4 M | 10.4 M | 10.4 M | 10.4 M | 3.16 M | 3.16 M | 3.16 M | 3.16 M | 4.13 M | 4.13 M | 4.13 M | 4.13 M | 919 K | 919 K | 919 K | 919 K |
Total Inventories |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency